Neha Krishnamohan - 02 Sep 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Neha Krishnamohan
Issuer symbol
ARQT
Transactions as of
02 Sep 2022
Net transactions value
$0
Form type
4
Filing time
06 Sep 2022, 19:08:12 UTC
Previous filing
02 Sep 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +29,482 $0.000000 29,482 02 Sep 2022 Common Stock 29,482 $24.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on each of September 2, 2023, September 2, 2024 and September 2, 2025, subject to Reporting Person's continuous service to the Issuer on each such vesting date.